baber/WOPTO huggingface dataset:
Patent PT-1596981-E (PT)
Title: Method and apparatus for controlling the recovery of solid polyolefin from a continuous reaction zone
Inventor: VERLEYSEN MARK
IPC: B01J19/18
Filed: 2005-02-09
Abstract: A polymerisation process and a loop reactor comprising polymerising olefins in a liquid diluent to produce a liquid slurry containing particles of normally solid polymer within the loop reactor, allowing the polymer to settle in a settling leg, periodically opening a 180 DEG rotating product take-off valve located at the end of the settling leg to allow a charge of particles to flow out of the settling leg, the product take-off valve being operated by a pneumatically driven double-acting actuator, the pneumatic system being regulated by a system comprising pneumatic control valves, the improvement which consists in using automatic control valves, which are automatic V-ball valves. <IMAGE>
Patent PT-1785122-E (PT)
Title: Device for adjusting the lying surface of an operating table
Inventor: FRUEH MICHAEL
IPC: A61G13/02
Filed: 2006-11-03
Abstract: The apparatus (10) has segments (14a-14f) adjustable in relation to one another by actuators (16a-16f). An operating instrument (18) has an electronic control unit (22), which is connected to an operating face (20), a store (24) and the actuators via signal lines (28). A diagrammatic image of a human body is located in a portion of the operating face, where buttons are located on left and right of the image for an input of body-related adjustment commands. A button is located at the lower end of the operating face for selecting one of operating modes in which the apparatus is operated.
Patent PT-1843814-E (PT)
Title: Device for the transdermal stimulation of a nerve of the human body
Inventor: KRAUS THOMAS
IPC: A61N1/36
Filed: 2006-01-21
Abstract: The apparatus has at least one stimulation electrode (2) and at least one reference electrode (3). The electrodes are in contact with a control unit (4) and the control unit controls the application of electric current to the electrodes. The stimulation electrode and the reference electrode are arranged in or on a housing which is formed to be attached to or in the human ear.
Patent PT-1908665-E (PT)
Title: Method of preventing oversteering and automobile equipped with power-assisted steering preventing oversteering
Inventor: NOUILLANT CEDRIC
IPC: B62D6/00
Filed: 2007-09-28
Abstract: The method involves generating a signal e.g. sound and/or light alert signal, when an effort associated to the behavior of tires of front wheels (1) e.g. steering wheels, under deformation, exerted on a steering rack (6) decreases with respect to a lateral effort and a speed of rotation of a flywheel (2) is higher than a threshold speed, where movement of the rack is due to the effort, torque applied by the fly-wheel and power torque applied by an electric motor (5). A residual function of time is defined from the effort exerted on the rack and from the lateral effort exerted on the tires. An independent claim is also included for a motor vehicle equipping an electrical power assisted steering system for orienting a train of steering wheels.
Patent PT-2233616-E (PT)
Title: Processes for producing flameproof fiber and carbon fiber
Inventor: OYAMA TARO
IPC: D01F9/22
Filed: 2008-12-10
Abstract: There is disclosed a method of producing a pre-oxidation fiber in the production of the pre-oxidation fiber by subjecting a polyacrylic precursor fiber to pre-oxidation processing in an oxidizing atmosphere, including shrinking the precursor fiber as a pretreatment of pre-oxidation at a load of 0.58 g/tex or less in the temperature range of 220 to 260°C under conditions in which the degree of cyclization (I 1620 /I 2240 ) of the precursor fiber measured by a Fourier transform infrared spectrophotometer (FT-IR) does not exceed 7%, initially-drawing the precursor fiber at a load of 2.7 to 3.5 g/tex in an oxidizing atmosphere at 230 to 260°C in the ranges of the degree of cyclization of not exceeding 27% and of the density of not exceeding 1.2 g/cm 3 , and then subjecting the pre-oxidation fiber to pre-oxidation treatment. A carbon fiber of high strength and high elasticity that is appropriate for composite materials that exhibit high composite performance is obtained by continuously subjecting this pre-oxidation fiber to carbonization treatment.
Patent PT-2254598-E (PT)
Title: Combination of alpha 7 nicotinic agonists and antipsychotics
Inventor: BENCHERIF MEROUANE
IPC: A61K45/06
Filed: 2009-02-13
Abstract: The present invention relates to a synergistic combination of an alpha7 (a7) nicotinic agonist and an antipsychotic agent.
Patent PT-2261336-E (PT)
Title: Dna-sequence and recombinant production of group 4 major allergens from cereals
Inventor: FIEBIG HELMUT
IPC: A61K38/095
Filed: 2004-12-01
Abstract: DNA molecules (I), corresponding to the sequence of the major allergens of cereal pollen are new. (I) have sequences (1; 1603 nucleotides (nt)); (3; 1644 nt); (5; 1608 nt); (7; 1603 nt) or (9; 1603 nt), all reproduced. DNA molecules (I), corresponding to the sequence of the major allergens of cereal pollen comprise sequences comprising 1603 nucleotides (SEQ ID No.:1) (nt)); 1644 nucleotides (SEQ ID No.:3; ); 1608 nucleotides (SEQ ID No.:5; ); 1603 nucleotides (SEQ ID No.:7; ) or 1603 nucleotides (SEQ ID No.:9; ). Independent claims are also included for: (1) DNA (Ia) that hybridizes to (I) under stringent conditions and is derived from DNA of Poaceae; (2) DNA (Ib) that encodes a polypeptide that is immunologically cross-reactive with the major allergens Sec c 4 ( Secale cereale); Hor v 4 ( Hordeum vulgare) or Tri a 4 ( Triticum aestivum) and derived from Poaceae; (3) DNA fragment, or combination of fragments, of (I), (Ia) or (Ib) that encodes an immunomodulatory T-cell reactive fragment (X) of Group 4 Poaceae allergens; (4) a DNA corresponding to any of the new DNAs or fragments that encodes an (X) but is modified by targeted mutation of individual codons, deletion or addition; (5) recombinant DNA expression vector or cloning system containing any of the new DNAs linked to expression control sequences; (6) host organism transformed with any of the new DNAs or the vector of (5); (7) preparing a polypeptide (II) encoded by the new DNAs by culturing the organisms of (6); and (8) (II) having any of the sequences, comprising 518 amino acids (SEQ ID No.:2; 520 amino acids (SEQ ID No.:4; ); 518 amino acids (SEQ ID No.:6; ); 518 amino acids (SEQ ID No.:8) or 518 amino acids (SEQ ID No.: 10; ) or their mature forms. ACTIVITY : Antiallergic. No biological data given. MECHANISM OF ACTION : Vaccine.
Patent PT-643608-E (PT)
Inventor: FOLENA-WASSERMAN GAIL
IPC: A61K38/00
Filed: 1993-03-24
Abstract: This invention relates to the application of combination chromatography to the purification of complement receptor proteins.
Patent PT-839050-E (PT)
Inventor: BHOGAL BALDIR S
IPC: A61P31/00
Filed: 1993-09-21
Abstract: A method of enhancing a specific cell mediated immune response, preferably in swine, involving vaccinating female animals with a selected (Mycoplasma) immunogen, so that subsequent vaccination of the newborn with the same immunogen elicits an enhanced CMI response as compared to newborns of non-vaccinated mothers.
Patent PT-714441-E (PT)
Inventor: ACHATZ GERNOT
IPC: C12N1/21
Filed: 1994-08-24
Abstract: The invention relates to recombinant DNA molecules that code for polypeptides that have the antigenicity of the allergens Clah53, Clah47, Clah22 and Clah11 or for peptides that have at least one epitope of these allergens. These molecules are characterized in that they have nucleic acid sequences that homologously match the sequences, 1, 3-5, 7-9, 12-14 as well as 16 and 17, or with segments of these sequences, or have nucleic acid sequences that hybridize with the indicated nucleic acid sequences under stringent conditions.
Patent PT-751781-E (PT)
Inventor: LONGO DAN L
IPC: C07K19/00
Filed: 1994-12-21
Abstract: There is disclosed a method of treating a mammal afflicted with a disease characterized by neoplastic cells that express CD40, comprising administering a therapeutically effective amount of a CD40 binding protein in a pharmaceutically acceptable buffer. CD40 binding proteins include monoclonal antibodies to CD40, and CD40 ligand. CD40 binding proteins may also be used to prevent disease characterized by neoplastic cells that express CD40, in individuals at risk for such disease.
Patent PT-787373-E (PT)
Inventor: SINCLAIR JOHN ASHTON
IPC: H02G5/04
Filed: 1995-10-12
Abstract: A flexible electrically conductive track including an elongated flexible insulating member providing at least one longitudinally extending slot to receive an electric conductor. The conductor includes a pair of generally parallel co-extensive contact strips joined by a plurality of transverse ribs. The slots are closed by resiliently displaceable flanges which are displaced to provide access to the conductor.
Patent PT-820545-E (PT)
Inventor: SMITH DAVID
IPC: D21C11/06
Filed: 1996-04-11
Abstract: An apparatus for introducing a high volume, low concentration non-condensable gas, which may contain sulfur into a chemical recovery steam generator furnace comprising: a plurality of gas inlet pipes, each gas inlet pipe having a source end and a nozzle end, in which the source end of the pipe is connected to a source of said high volume, low concentration non-condensable gas and the nozzle end of the pipe, which comprises a nozzle, vents to said chemical recovery steam generator furnace; a preheater positioned in close proximity to said pipe and upstream of said nozzle; a secondary air port with a source end and a furnace end, in which the source end of said port is connected to a source of such secondary air and the furnace end of said port vents to said chemical recovery steam generator furnace; wherein the area enclosed by said secondary air port is greater than the area of said nozzle and wherein said nozzle is positioned within the area enclosed by said secondary air port such that said pipe and said port are substantially co-axial with respect to one another is described.
Patent PT-855052-E (PT)
Inventor: SIGBJORNSEN SIGURD
IPC: G06F21/12
Filed: 1996-07-10
Abstract: An arrangement to protect software, particularly freely distributed application software, against utilization without permission of the copyright holder. By encrypting the software employing a key (k1) which is different from that key (k2) which is employed in the decryption, better protection is obtained against unauthorized utilization when the decryption key is kept secret to the user. Further improved security is achieved by additionally executing scrambling-descrambling of the communication between the computer in which the software is utilized and the external unit in which the decryption key is stored. Also, the external unit is arranged such that it returns to the host computer, the result from its processing of data received from the host, the result then being utilized in the further execution of the respective program. <IMAGE>
Patent PT-907621-E (PT)
Inventor: STOETZEL REINHARD
IPC: B01D39/20
Filed: 1997-05-30
Abstract: The disclosed invention relates to the field of ceramics and concerns an open-cell expanded ceramic which may be used in the form of a deep-bed filter, and a process for the production thereof. The primary object is to produce an open-cell expanded ceramic by a simple and economical process. This object is attained by an open-cell expanded ceramic in which the inner cavities, cracks and the porosity of the ceramic members are filled partially or completely by one or a plurality of metal and/or ceramic phases and/or glass phases. The open-cell expanded ceramic is also produced in that during or after sintering the cavities, cracks and the porosity of the ceramic members are partially or completely filled with a melt or a suspension which melt below the melting temperature of the expanded ceramic, have a coefficient of expansion similar to the coefficient of expansion of the expanded ceramic, and a very good wetting capacity, and only react partially or not at all with constituents of the expanded ceramic.
Patent PT-941221-E (PT)
Inventor: KLEY HANS-PETER
IPC: C07F9/655
Filed: 1997-11-11
Abstract: PCT No. PCT/EP97/06248 Sec. 371 Date Apr. 16, 1999 Sec. 102(e) Date Apr. 16, 1999 PCT Filed Nov. 11, 1997 PCT Pub. No. WO98/22453 PCT Pub. Date May 28, 1998Compounds of formula (I) and the salts of these compounds, are efficacious PDE (phosphodiesterase) inhibitors.
Patent PT-954478-E (PT)
Inventor: ZETTLE JEFFREY J
IPC: B29C49/06
Filed: 1997-12-12
Abstract: A collapsible container having a generally cylindrical configuration including at least an upper thicker section and a lower thicker section, and at least one thinner section positioned between the upper and lower thicker sections. When the container is collapsed, the upper and lower thicker sections are telescoped within one another and the thinner section is folded therebetween. The container is made of a monolayer of a thermoplastic polymer having a flex modulus of from 60,000 to 160,000 psi and a heat distortion temperature at 66 psi of greater than 170 degrees F. A process for making the collapsible container using extrusion blow molding is also disclosed.
Patent PT-990811-E (PT)
Inventor: OETIKER HANS
IPC: F16J3/04
Filed: 1998-10-02
Abstract: The jacketing has a bellows-type part (10) with a collar-like ring-shaped section (14) at each end. An open clamp/press/shrink ring (20) resp. open hose clip, esp. multi crimp ring, on the end section is pre-tensioned in direction of the center, so that both ends (22,24) overlap and the ring/clip is automatically locked on the end section. Both ring ends have interlocking parts (23). The collar-like ring part has a retainer part (16) to hold it on the end section when in open non-mounted condition.
Patent PT-895537-E (PT)
Inventor: MARK ACHTMAN
IPC: C07K14/22
Filed: 1998-01-20
Abstract: The present invention is concerned with a fragment of IgA1-protease having 40 to 200 amino acid residues and comprising at least 40 amino acids of an amino acid sequence as shown in SEQ ID NO:1, beginning with the amino acid in any one of positions 1 to 5 and ending with an amino acid in any one of positions 40 to 104 or a homologous sequence, its use as a carrier for a conjugate, particularly in combination with a polysaccharide, and a process for producing the peptide as well as vaccines comprising said peptide.
Patent PT-970042-E (PT)
Inventor: CAVALLERI PAOLO
IPC: A61K31/135
Filed: 1998-02-04
Abstract: PCT No. PCT/EP98/00589 Sec. 371 Date Jul. 16, 1999 Sec. 102(e) Date Jul. 16, 1999 PCT Filed Feb. 4, 1998 PCT Pub. No. WO98/38155 PCT Pub. Date Sep. 3, 1998Compounds of formula (I) wherein R1 and R2 are independently hydrogen or an optionally branched C1-4 alkyl group; the asterisk marks an asymmetric carbon atom; and the pharmaceutically acceptable salts thereof, useful in cardiovascular field, are described.
Patent PT-1032672-E (PT)
Title: Dna19355 polypeptide, a tumor necrosis factor homolog
Inventor: ASHKENAZI AVI J
IPC: C07K14/435
Filed: 1998-11-18
Abstract: A tumor necrosis factor homolog, identified as DNA19355, is provided. DNA19355 polypeptide has apoptotic activity in mammalian cancer cells and may be involved in proinflammatory responses. Nucleic acid molecules encoding DNA19355, chimeric molecules and antibodies to DNA19355 are also provided.
Patent PT-1052909-E (PT)
Inventor: RODGER GRAHAM WOOD
IPC: A23L1/28
Filed: 1998-12-11
Abstract: Flavouring materials may be produced from filamentous fungi by contacting them with water at a temperature sufficient to reduce their nucleic acid content and concentrating or separating solids from the resulting aqueous solution. The materials are then further subjected to a chemical reaction for example with a sulphur containing amino acid.
Patent PT-1035982-E (PT)
Inventor: MASTROIANNI CESARE
IPC: B60K7/00
Filed: 1998-12-10
Abstract: A vehicle drive assembly with a drivable wheel pivotably connected to a body, about an axis substantially transverse to the body, by first and second swing arms. One of the swing arms houses a motor and includes a heat dissipating member in thermally conductive association with the motor. The heat dissipating member preferably a plurality of cooling fins exposed to ambient air. The motor is housed in an end of the first swing arm opposite the body, and has a shaft that is directly engaged to a transmission within the wheel. The transmission is contained within a gearbox housing that rotates with the wheel and is formed by left and right structural gearbox halves. A wheel rim, configured to carry a tire, is attachable only to the first gearbox half, and can slide over the second half when removed from the gearbox housing, allowing the transmission to remain assembled. The interior of the gearbox housing contains a lubricant, and a vent is formed generally parallel to the motor shaft and extending through the first swing arm. Preferably, the second swing arm is detachable from the transmission while remaining substantially stationary in a direction substantially coaxial with the axle. Also, the transmission preferably includes a planetary gear reduction unit, in which planetary gears are mounted on a gear carrier that is configured to prevent rotation caused by the motor.
Patent PT-943701-E (PT)
Title: Process and reactive solution for producing a patina
Inventor: HOVELING STEFAN
IPC: C23C22/52
Filed: 1999-02-13
Abstract: A patina is produced on a copper article using a reactive aqueous solution of copper salts and inorganic acid salts. A patina is produced on the surface of a copper or copper alloy article by cleaning the surface, applying an aqueous solution of copper salts and salts of inorganic acids and then drying while protecting against the weather. An Independent claim is also included for a reactive solution used in the above process and comprising an aqueous solution of copper salts and inorganic acid salts, preferably together with a wetting agent and a thickener.
Patent PT-980847-E (PT)
Inventor: AIMAR GIACOMO
IPC: C03B33/07
Filed: 1999-08-12
Abstract: A cutting table (1) for processing sheets (2) of glass has a supporting frame (4, 5) defining a supporting surface (6) for a sheet (2) for processing, at least one powered gantry structure (7), and a powered carriage supporting a notching tool (16), the gantry structure and the carriage sliding over the supporting surface (6) in two different directions; the table (1) also having a tracing station (20) forming at least part of the supporting surface (6), a tracing device (21) located at the tracing station (20) to trace a reference path (P1), and a control unit (18) for moving the notching tool (16) over the supporting surface (6) and along at least one given path (P) as a function of the reference path (P1) traced and memorized in the control unit (18). <IMAGE>
Patent IE-870134-L (IE)
Title: 1, 4-dihydropyridines
IPC: C07D491/153
Filed: 1987-01-20
Abstract: Compounds of the formula <IMAGE> VI are disclosed wherein the variables are herein described. These compounds are intermediates to compounds which influence the influx of calcium into the cell.
[US4766213A]
Patent IE-32761-L (IE)
Title: Composite container
IPC: B65D23/00
Filed: 1969-02-13
Abstract: 1,261,248. Composite construction containers. OWENS-ILLINOIS Inc. 13 Feb., 1969 [13 Feb., 1968], No.7739/69. Addition to 1,185,901. Heading B8D. A composite construction container of the kind claimed in claim 1 of the parent Specification is characterized in that the single-walled glass body 51 is circular throughout in section perpendicular to an axis of rotational symmetry and comprises, in addition to the substantially continuously convexly arcuate bottom portion 51a, a contiguous cylindrical portion 51b of substantially equal axial extent and of a diameter equal to the maximum diameter of the body, and a convexly tapering portion 51c extending between the cylindrical portion 51b and a concavely curved minimum diameter neck portion 52 and having an axial extent substantially equal to the combined axial extents of the bottom and cylindrical portions 51a, 51b, the neck portion 52 having a flared portion 53 which terminates in a lip 54. The base 70, which is in the form of a cup, extends over the base of the body and at least up to the converging portion 51b of the body and may be secured to the latter by heat shrinking, or an adhesive. The base of the cup comprises an outer annulus 72 with a yieldable wall 73 which is connected to a concave body supporting-portion 74. The latter has pressed out downwardly therefrom an interrupted circular array of ribs 74a each with end walls 74c, the ribs normally extending above the base of the annulus 72. When a force is applied vertically downwardly upon the neck 52, for instance during capping, the wall 73 allows the grooves 74a to descend on to a supporting surface and provide a back-up for the applied force. The base has vent holes 74b which can be closed by placing spots of adhesive on outer surface of the lower surface 51a of the body before it is introduced into the cup. In a modification, Fig. 4 (not shown), the inwardly facing wall (83) on the base annulus (82) is connected to a raised flat bearing support surface (84) which also provides a surface for stacking composite containers.
[GB1261248A]
Patent IE-32656-L (IE)
Title: 3,4-dihydroisoquinoline derivatives
IPC: C07D317/52
Filed: 1969-03-05
Abstract: 1,264,485. Dihydroisoquinoline derivatives. RHONE-POULENC S.A. 5 March, 1969 [6 March, 1968; 20 Jan., 1969], No. 11828/69. Heading C2C. Novel compounds I wherein (i) the symbols R are the same or different and each is H or OCH 3 , R 1 is H and R 2 is alkyl, cyanoalkyl, dialkylaminoalkyl, phenylalkyl or amino, or NR 1 R 2 is a 1-piperazinyl group or a 4-alkyl-1-piperazinyl group; (ii) the symbols R, R 1 and R 2 all represent H or (iii) one R is halo and the other is H, halo or OCH 3 or together the symbols R represent -OCH 2 -O-; R 1 is H and R 2 is dialkylaminoalkyl and their acid addition and quaternary ammonium salts are prepared by reacting NH 3 or an amine HNR 1 R 2 with a compound II wherein R 3 is 1-3C alkyl or an acid addition salt thereof. Intermediates isolated are 1-methylthio-6,7- dimethoxy - 3,4 - dihydroisoquinoline (A), prepared by reacting 6,7-dimethoxy-3,4-dihydroisothiocarbostyril with methyl iodide; 6,7- dimethoxy - 3,4 - dihydroisothiocarbostyril (B), which is prepared by cyclization of 2-(3,4- dimethoxyphenyl)-ethyl isothiocyanate (C), which in turn is prepared from 2-(3,4-dimethoxyphenyl) - ethylamine and thiophosgene; 1- methylthio - 6,7 - methylenedioxy - 3,4 - dihydroisoquinoline (D), prepared from methyl iodide and 6,7 - methylenedioxy - 3,4 - dihydroisothiocarbostyril (E), which is prepared by cyclization of 2 - (3,4 - methylenedioxyphenyl) - ethyl isothiocyanate (F) (prepared by reacting 2-(3,4- methylenedioxyphenyl) - ethylamine with thiophosgene); 2 - (4 - chlorophenyl) - ethyl isothiocyanate (G), prepared by reacting 2-(4-chlorophenyl)-ethylamine with thiophosgene; 3,4- dihydro - 7 - chloro isothiocarbostyril (H) prepared by cyclization of (G); and 7-chloro-1- methylthio - 3,4 - dihydroisoquinoline (I), prepared by reacting (H) with methyl iodide. Pharmaceutical compositions comprise a compound I in association with a pharmaceutical carrier or coating, are administered orally, parenterally or rectally and are used as antitussive agents and anti-fibrillation agents. (From GB1264485 A) [FR2028672A6]